Cervarix?, GSK's Cervical Cancer Vaccine, Wins Tender For UK National Immunisation Programme
Cervarix?, GSK's Cervical Cancer Vaccine, Wins Tender For UK National Immunisation Programme
GlaxoSmithKline's (GSK) cervical cancer vaccine, Cervarix TM, was confirmed as the UK Department of Health's vaccine of choice for its national human papillomavirus (HPV) immunisation programme. The programme, which aims to protect against the two types of HPV that are responsible for approximately 70% of cervical cancers1, will start in September 2008 and will vaccinate girls aged 12 to 13 each year.
What next?
Posting Komentar